PharmaLedger.org
Join the network
The Association

A non-profit owned by
everyone in the network.

PharmaLedger is governed by the people who use it. Every member organization holds equal weight in the architecture decisions, the roadmap, and the bylaws — because a trust fabric only works if no single party owns it.

Become a member Read the bylawsBuilding a Digital Trust Ecosystem
Mission

A trust fabric, openly governed.

We exist to give healthcare a neutral, open, member-governed trust layer for product information — one designed to connect, not to replace, the infrastructure already in place. Patient safety, regulatory integrity, and member sovereignty come before any single firm’s commercial interest.

Origin
EU IMI 2020
HQ
Zurich, CH
Legal form
Non-profit assoc. (CH)
Code
Open source
Timeline
2020
EU IMI project begins
PharmaLedger launches under Horizon 2020 — Novartis industry lead, €22.1M from EU & EFPIA
2022
Association established
IMI project concludes; PharmaLedger Association formed to take the work to production
2023
First product & members
ePI announced and in production; first member organizations join
2025
AstraLabel launch
New partnerships and leadership appointments across the ecosystem
2026
Product Trust Platform 2.0
PTP 2.0 launch and AstraLabel deployment
Members & partners

Pharma, tech, academia
& patient organizations.

The work began as an EU IMI consortium of 29 partners — 12 global pharma plus 17 public and private organizations. From global manufacturers to technology providers, research institutes and patient groups, every member governs their own data and shares verified trust with everyone else.

GSK
FOUNDING · PHARMA
MSD
FOUNDING · PHARMA
AbbVie
FOUNDING · PHARMA
Takeda
FOUNDING · PHARMA
Moderna
PHARMA
Elanco
ANIMAL HEALTH
Zuellig Pharma
DISTRIBUTION
Glemser Technologies
TECHNOLOGY
PDMFC
TECHNOLOGY
RomSoft
TECHNOLOGY
Partisia Blockchain
TECHNOLOGY
allpack Pharma Packaging
PACKAGING
CERTH
RESEARCH
European Patients Forum
PATIENTS
Interoperability Institute
FHIR · STANDARDS
+ more
SEE ALL MEMBERS →
Governance

Decentralized by design.

A Board of Directors appointed by the members, with a chair and vice-chair elected from its number. The Executive Director is the officer running day-to-day operations. Decisions follow one organization, one vote — and product committees and working groups (such as the AstraTrace Committee) steer each part of the roadmap.

Read the full charter
Officers & leadership
SS
Dr. Stefan Schwarzfischer
Executive Director
Profile →
JG
James Gannon
VP of Product & Technology
Profile →
SA
Sam Andrews
Director of Quality, Trust & Safety
Profile →
CD
Clarisse Dias da Mota
VP of Ecosystem Ops & Strategy
Profile →
BoD
Board of Directors
Appointed by members; chair & vice-chair elected annually. Current roster in the bylaws.

A neutral, non-profit ecosystem — members govern the roadmap, own their data, and share verified trust with everyone else. Designed to connect, not to replace.

PL
PharmaLedger AssociationMember-governed · Zurich
Designed with the industry · founding research partners, EU IMI programme 2019–2022
AbbVieAstraZenecaBayerBoehringer IngelheimGSKJanssenMerck KGaANovartisNovo NordiskPfizerRocheUCB

A €22M, 29-partner research programme across 10 EU member states — requirements written by the companies that deploy it.

32+
members of the association
12
global pharma founders
3+ yrs
in production since 2022
0
unplanned departures, 2025 replatform
Join the network

What membership gives you.

There are no published tiers or fees — any organization with a vested interest in healthcare should join. Members pool resources to build and run qualified, fully-tested solutions, and every member gets one vote: governance is one-org, one-vote regardless of size.

Beyond governance · 01
Qualified solutions

Access to qualified, fully-tested solutions built and run by the ecosystem — and the ability to market them via the PLA network.

Beyond governance · 02
Roadmap influence

Working groups write the spec before it ships — members shape what AstraLabel, AstraTrace, and AstraEngage become.

Beyond governance · 03
Submit & fund ideas

Propose new solution ideas for PLA funding and help direct where shared resources are invested.

Access

Access

Members
  • Access to qualified, fully-tested solutions
  • Participate in the open-source projects
  • Global collaboration across the ecosystem
Apply
Build

Build

Members
  • Operate a network node behind your firewall
  • Market your solutions via the PLA network
  • Direct onboarding and engineering support
  • Co-marketing and case study opportunities
Talk to us
Academic institutions, regulators & patient organizations
Any organization with a vested interest in healthcare is welcome — apply with a brief statement of interest.
Associate program
How joining works

From application to first vote.

STEP 01

Apply

Get in touch via the contact form with a brief statement of interest. Any organization with a vested interest in healthcare is eligible.

STEP 02

Review

The membership committee reviews the application — legal form, compliance posture, antitrust — and recommends to the board.

STEP 03

Provision your node

Your node goes live behind your firewall — self-hosted, or run for you by a certified managed partner.

STEP 04

Ratify & vote

Welcomed at the next assembly. One organization, one vote.

Deployment
What adoption actually takes

Use the platform as managed SaaS, or self-host a dedicated instance in your own AWS account — packaged as infrastructure-as-code for a small team. Either way: your keys, your data, encrypted under customer-managed keys.

Events

Where the network meets.

MEMBERS

Annual General Meeting

The all-member assembly where the board is appointed and members vote — one organization, one vote.

Members onlyHybrid
WORKING GROUPS

Product committee meetings

Product committees and working groups — such as the AstraTrace Committee — steer each part of the roadmap.

MembersRecurring
COMMUNITY

Open community sessions

Open sessions for the wider ecosystem and the open-source community to take part.

PublicOnline